CapsoVision, Inc. (CV)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Capsule Endoscopy	13.55M	11.76M	9.75M
Capsule Endoscopy Growth	15.29%	20.54%	-
Total	13.55M	11.76M	9.75M
Total Growth	15.29%	20.54%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
United States	10.66M	9.08M	7.24M
United States Growth	17.34%	25.46%	-
outside United States	2.90M	2.67M	2.51M
outside United States Growth	8.34%	6.36%	-
Total	13.55M	11.76M	9.75M
Total Growth	15.29%	20.54%	-

Data Source: S&P Global Market Intelligence Last updated: May 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error